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Endovascular treatment of abdominal aortic aneurysms with
Endologix® stent graft: single-site experiences and short-term
follow-up outcomes
Mustafa KAYAN1, Turhan YAVUZ2, Mustafa ETLİ2, Şeyma BENZİN1, Seda İBİŞOĞLU1,
Esma Dilek ÜSTÜN1, Mert KÖROĞLU1, Ergün CEYLAN1, Ulaş SAĞLAM2

Aim: The aim of this study was to investigate the short-term results of endovascular repair of abdominal aortic aneurysms
with the Endologix IntuiTrak Powerlink XL® (Endologix) stent graft and to share our clinical experiences in our center.
Materials and methods: Endovascular stent graft treatment was applied in 16 cases with infrarenal abdominal aortic
aneurysm (13 men and 3 women; mean age: 70.2 years) in 2009 and 2010. Before treatment, all of the patients were
examined with 128-slice computed tomography (CT) angiography for the assessment of abdominal aortic aneurysms.
The Endologix stent graft (bifurcated system) was used for all of the patients.
Results: The aneurysms of the 16 patients were located at the infrarenal level. They were treated with aortobiiliac stent
grafts. The technical success rate was 100%. No mortality, major complications, or need of urgent conversion to open
surgery occurred in any of the patients. Only 1 patient died due to acute coronary syndrome in the early follow-up
period and 1 patient was lost in the follow-up period. There were no aneurysm ruptures, graft migrations, or graft
fractures in any of the patients.
Conclusion: Endovascular treatment of infrarenal aortic aneurysms with the Endologix stent graft has a high degree of
technical success and is a useful alternative to surgery.
Key words: Infrarenal abdominal aortic aneurysm, endovascular aortic repair, computed tomography

Introduction
Endovascular aortic aneurysm repair (EVAR) was
first defined in 1989, and wide use of this method
has recently begun (1). Abdominal aortic aneurysms
(AAAs) are the most commonly observed among all
aneurysms, especially in patients over the age of 55
years. A substantial part of AAAs occurs distal to the
renal arteries. Reasons for increase in the incidence of
AAAs may include prolonged lifetime and important
advances in diagnostic methods (2,3). When
endovascular treatment is compared with surgery,
a remarkable decrease is found in complication and
mortality rates. The rate of perioperative mortality

is 4.6% following open surgery, whereas it is 1.2%1.6% following EVAR (3-6). Unless they rupture,
many AAAs may be asymptomatic, but abdominal
pain, back pain, and pulsatile abdominal mass
findings can be present in symptomatic AAAs.
The risk of rupture is related to aneurysm size. It
increases significantly with sizes over 5.5 cm. Elective
repair is required due to risk of rupture. The most
important disadvantage of EVAR is the inadequacy
of late period data (7-9). In our study, we aimed to
review 16 infrarenal AAAs treated with a new device
that is known as the bifurcated system. We also
aimed to review our clinical experiences as well as
short-term follow-up outcomes.
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Materials and methods

(10,11). Consent was obtained from all of the patients
before the procedure. The procedure was performed
under the supervision of a team of specialists
comprising a radiologist, cardiovascular surgeon, and
anesthesiologist in an angiography laboratory with
a fully equipped intensive care unit after necessary
sterilization and a sterile operating environment
were ensured. All of the patients were examined with
a 128-slice computed tomography (CT) angiography
device in terms of eligibility for EVAR. Mean blood
loss was estimated at 200 cc. During the procedures,
a mean of 180 cc of contrast medium was used.
Using 3-dimensional CT angiography images, the
diameters of the infrarenal abdominal aorta and iliac
and femoral arteries, the presence of intraluminal
thrombus, wall calcification, intraluminal flow,
length of the aneurysm in which the stent would be
placed, and type and size of the graft to be used were
examined (Table 1). Moreover, the angle between the
aneurysm and the iliac artery was examined in detail.

Endovascular abdominal stent graft treatment
was applied in a total of 16 cases of nonruptured
infrarenal abdominal aortic aneurysms (13 men and
3 women; mean age: 70.2 years, range: 58-87 years)
in 2009 and 2010. Patients with open aneurysms,
inflammatory aneurysms and suprarenal extension,
presence of underlying connective tissue disease,
underlying cancer or previous stroke, ineligibility
for follow-up, and serious distal arterial circulation
problems were not included. Symptomatic or
asymptomatic infrarenal AAA cases with the
following criteria were included: the widest diameter
was over 5 cm, the femoral or iliac arteries were
suitable for endovascular intervention, there was
presence of recoverable peripheral arterial disease,
the nonaneurysmatic diameter of the proximal
aneurysm neck was between 18 and 26 mm, and the
aneurysm neck length was adequate for attachment
of the graft at the most inferior level of the renal ostia

Table 1. Before the procedure, infrarenal level measurements by multidetector CT. P: patients, L1: infrarenal aneurysm neck length,
L2: infrarenal aneurysm neck diameter of transfers, L3: infrarenal aneurysm diameter of the widest transfers, L4:
open lumen diameter of the widest transfers of infrarenal aneurysms, L5: distance of renal artery-iliac bifurcation, A°:
angulation of the aneurysm neck, B°: angulation of the iliac arteries, C: iliac artery diameters.
B°
P
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L1 (cm)

L2 (cm)

A°

L3 (cm)

L4 (cm)

C (cm)

L5 (cm)
Right

Left

Right

Left

1

2.5

2.5

126

6.5

4.3

15.0

124

130

0.6

1.2

2

3.0

2.3

147

5.9

4.2

14.2

120

128

0.7

0.9

3

2.0

1.8

99

8.0

5.9

10.6

163

147

1.4

1.7

4

5.1

2.2

98

5.7

5.7

11.5

145

178

1.3

1.1

5

1.0

1.8

116

6.8

5.7

11.3

160

137

0.7

0.9

6

2.8

2.1

163

5.4

4.0

10.6

133

153

0.8

0.7

7

2.3

1.9

138

5.3

4.3

11.3

130

145

1.2

0.9

8

2.4

2.4

142

5.4

5.4

12.7

136

142

1.1

1.3

9

1.8

2.3

155

6.2

5.2

11.2

144

139

1.4

1.3

10

1.6

2.1

128

5.2

3.4

10.5

134

138

1.5

1.3

11

2.2

2.1

104

5.3

2.8

12.4

121

123

1.8

1.7

12

2.3

2.1

110

6.4

3.2

13.7

140

120

1.5

1.2

13

2.4

2.2

120

5.1

3.7

11.6

115

140

2.0

1.5

14

2.5

2.4

102

7.2

5.6

14.5

120

114

1.8

1.5

15

2.7

2.2

120

6.0

2.8

15.0

112

116

1.9

1.1

16

2.5

2.1

119

6.7

2.6

14.0

118

125

2.1

1.5
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Procedure
Patients were evaluated hematologically and
systemically. All of the patients were monitored and
the procedures were performed by administering
local anesthesia and sedation. Cefazolin (1 g) was used
prophylactically before the procedure. An injection
of heparin (1 cc = 5000 units) was administered
during the procedure and it was repeated depending
on the duration of the procedure if required. In all
of the cases, the Endologix IntuiTrak Powerlink XL®
(Endologix) stent graft (bifurcated system), which is
a new device in this type of treatment, was used. The
right iliac artery was surgically prepared in order to
advance a 21F graft, and a 12.5F peel away introducer
(vascular sheath) was placed. In order to place the
leg of the stent graft on the contralateral side and
to obtain control angiography, a 9F vascular sheath
of 11-12 cm in length was placed. When the size of
the stent graft was selected, sizes of 5 mm more than
the diameter of the aortic neck as measured in CT
were preferred. Values measured by angiography,
performed by imaging the vascular sheath placed
into the left iliac artery and by CT angiography, were
confirmed before the procedure. Later, a passage
was formed between the bilateral iliac arteries with
a guide wire, using a snare catheter. A double-lumen
catheter was placed over the guide wire. The rigid
guide wire advanced from the right iliac artery and
was fixed to a point in close proximity to the aortic
arch. Physiological serum was prepared by priming
from all spaces of the graft taken to the table. The
graft was loaded onto the rigid guide wire in the right
iliac artery, and the contralateral leg was released
when the bifurcation level was reached. The graft was
seated on the bifurcation by withdrawing towards the
iliac arteries and, thus, first the main body and later
the contralateral and ipsilateral legs were opened.
An aortic extension on the main body was used in
all of the patients. Meanwhile, after performing
the aortography, localization of the renal arteries
was determined and marked. Later, some technical
adjustments were made: a 2-cm uncovered section of
the graft at 2 cm above the renal arteries was slowly
withdrawn under fluoroscopy and fixed at the renal
level. In the repeated aortography, dilatation was
provided with an aortic occlusion balloon under
necessary conditions. After the procedure, patients
were monitored in the intensive care unit, vital

findings were followed closely, and, later, the patients
were transferred to the cardiovascular surgery service
for follow-up. Patients were discharged following
a 2-day hospitalization period. Patients with no
postprocedure complaints were instructed to attend
a check-up visit with Doppler ultrasonography after
3 months. Graft migration, intraluminal flow, and
endoleakage were evaluated with contrasted thoracic
and abdominal multislice CT (MSCT) performed
after 6 months.
Results
The risk factors associated with the patients are
given in Table 2. Of the patients with pretreatment
American Society of Anesthesiologists (ASA)
scores of III and IV, 4 were in the high-risk group.
The common symptoms were abdominal pain and
reflective back pain. Not included was one patient
who was ineligible for follow-up due to serious distal
arterial circulation problems. There was a complaint
of claudication occurring when walking a distance of
100-150 m in one case, but there were no secondary
skin findings associated with an arterial disease.
In all of the cases, there was at least one additional
pathology related to infrarenal aortic aneurysms.
In all of the cases, femoral arteries were selected as
the insertion site and an aortobiiliac stent graft was
placed. When necessary, the system was extended
to the level of the renal artery by placing an aortic
extension on the main body. Early patient followup outcomes were evaluated at 1, 3, and 6 months.
Table 2. The patients’ risk factors and accompanying diseases.
Parameters

Number

Percent (%)

Age > 70 years

8

50

Hypertension

7

44

Cardiac disorder

6

38

Peripheral arterial occlusive disorder

4

25

Smoking

9

56

Type II diabetes mellitus

1

6

Renal function impairment

1

6

Symptomatically

16

100

ASA class I

6

38

ASA class II

6

38

ASA class III-IV

4

25
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A primary leak occurred in 1 patient during the
procedure, which was observed at the 1-, 3-, and
6-month follow-up evaluations. It was completely
thrombosed and had completely disappeared. In
one case, the localized stenosis found in the external
iliac artery was treated using the balloon angioplasty
method in order to facilitate interventions. We were
informed that a female patient in the high-risk group
(ASA IV) died due to acute coronary syndrome. One
patient was lost in the follow-up period. Rupture,
graft migration, and stent breakage were not found
in any of the patients (Figure 1). In all of the patients,
preoperative aneurysm diameters and diameter
measurements were evaluated at month 6 (Table 3).
MSCT abdominal angiography was performed in
month 6 following the procedure in all of the cases
under follow-up. If the open lumen diameter of
the aorta was reduced to below 3 cm, the outcome
(A)

was regarded as successful (Figure 2). Migration,
recurrence of the aneurysm, and occlusion were not
found.
Discussion
Most aortic aneurysms are nonspecific with no
particular reason, whereas there is an underlying
pathology, such as congenital connective tissue
diseases
(Marfan
syndrome,
Ehlers-Danlos
syndrome, etc.), vascular malformations, infections,
noninfectious inflammations, vasculitis (Takayasu
disease, temporal arteritis, etc.), in less than 5% of
cases (12,13). None of our patients were connected
to specific pathologies as mentioned above, probably
for many reasons. AAAs are the most commonly
seen aneurysms. It is believed that 1 out of every
200 deaths in the world is related to AAAs. It is most

(B)

(C)

(E)

Figure 1. Abdominal CT of a 72-yearold female patient who
presented with acute severe
abdominal pain. Axial (A),
coronal maximum intensity
projection (B), and volume
rendering
technique
(VRT) (C) images show
an
infrarenal
abdominal
aortic
aneurysm.
Digital
subtraction angiography of the
aneurysm prior to and after
stent graft insertion is also
shown (D and E).

(D)
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(B)

(C)

(A)

Figure 2. CT images of the same patient 6 months postoperatively: contrast-filled lumen (yellow arrow) and the thrombosed aneurysm
(green arrow) on an axial CT image (A); bifurcated stent graft VRT image (B and C).
Table 3. Comparison of aortic diameters preoperatively and at month 6. L3: Infrarenal aneurysm diameter of the widest transfers, L4:
open lumen diameter of the widest transfers of infrarenal aneurysms, L6: infrarenal aneurysm diameter of the widest transfers,
L7: open lumen diameter of the widest transfers of infrarenal aneurysms, A: decrease in the widest diameter, B: decrease in the
open lumen diameter of the widest transfers of infrarenal aneurysms.
Preoperative

Postoperative

Patients
L3 (cm)

L4 (cm)

L6 (cm)

L7 (cm)

A (cm and %)

B (cm and %)

1

6.5

4.3

2.6

2.5

3.9 (60%)

1.8 (42%)

2

5.9

4.2

2.8

2.8

3.1 (53%)

1.4 (33%)

3

8.0

5.9

5.0

2.8

3.0 (38%)

3.1 (53%)

4

5.7

5.7

2.6

2.6

3.1 (54%)

3.1 (54%)

5

6.8

5.7

2.1

2.1

4.7 (69%)

3.6 (63%)

6

5.4

4.0

3.8

2.7

1.6 (30%)

1.3 (33%)

7

5.3

4.3

2.2

2.2

3.1 (59%)

2.1 (49%)

8

5.4

5.4

3.8

2.9

1.6 (30%)

2.5 (46%)

9

6.2

5.2

3.8

2.8

2.4 (39%)

2.4 (46%)

10

5.2

3.4

3.5

2.6

1.7 (33%)

0.8 (24%)

11

4.8

2.8

3.2

2.4

1.6 (33%)

0.4 (14%)

12

6.4

3.2

4.6

2.7

1.8 (28%)

0.5 (16%)

13

5.1

3.7

4.9

2.4

0.2 (4%)

1.3 (35%)

14

7.2

5.6

5.3

2.6

1.9 (26%)

3.0 (54%)

15

6.0

3.5

-

-

-

-

16

6.7

2.6

-

-

-

-

commonly observed at the infrarenal level (95%)
because the elastin layer is weaker at this level (14).
EVAR is preferred over surgery for patients
requiring treatment. This method is applied to
approximately 50,000 subjects each year worldwide

(15). The Endologix device used in this study is
different from those previously used. In this system,
the contralateral leg is on the main body and the
procedure is performed with unilateral arteriotomy.
Although bilateral arteriotomy is routinely used
827
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in EVAR, unilateral arteriotomy is sufficient for
endovascular treatment with bifurcated systems.
Therefore, unilateral arteriotomy is a superior
feature of this device. The system attaches to the
healthy neck, beneath the iliac bifurcation and renal
arteries, and migration is prevented by a doublesided safety mechanism. As the system is supported
by iliac bifurcation, it may be used in aneurysms
with a healthy neck of less than 1.5 cm. The 21F
delivery system placed into the arteriotomy site can
also be used as a hemostatic valve. The main body
has an infrarenal design and this device prevents any
lateral or downward extension. In 80% of Endologix
cases, an aortic extension is required. In our study,
the Endologix bifurcated system was used in all
of the patients and an aortic extension was placed
in all of the patients, and graft migration was not
observed at follow-up. In 1 patient, the length of the
neck to which the aneurysm was attached measured
1 cm in diameter. In a study group of 7 patients
with advanced age and comorbidities, Rahman et
al. (16) reported that aortic stent graft treatment
was successfully performed instead of the surgical
method in the treatment of infrarenal aneurysms
in 6 patients and a thoracic aneurysm in 1 patient,
using Medtronic Talent® (Medtronic Vascular, Santa
Rosa, California, USA). A bilateral arteriotomy
was performed in 6 patients with aortobiiliacs, for
whom stent grafts were inserted. In our study, the
EVAR method was performed instead of surgery by
using the bifurcated system. Additionally, for all of
the patients in our study, the stent graft was placed
by unilateral arteriotomy. Similar to the present
study, Tom et al. (17) used the bifurcated system in
7 patients, using a different device called the Prostar
XL® system (Abbott Vascular, Abbott Park, Illinois,
USA) with unilateral arteriotomy. Although the
endovascular treatment method is used in some
centers in Turkey, the bifurcated system is not

widely used. Therefore, new studies are needed for
technical optimization and long-term results with
the Endologix stent graft.
The EVAR treatment method is performed
all around the world under the cooperation of
interventional radiologists, cardiovascular surgeons,
and anesthesiologists. In the present study, all of the
procedures took place in the interventional radiology
unit and included the participation of the abovementioned team. Conversion to open surgery may
be performed during endovascular treatment or at
a later period (18). The reason for the absence of
conversion to surgery in our study may be the low
number of patients and lack of long-term data.
The most commonly observed complication of
endovascular treatment is leakage, the incidence of
which varies between 10% and 50%. It is known that
most primary leakages may be due to spontaneous
thrombosis. If leakages do not result in thrombosis
but persist, they are referred to as persistent leakages,
and the approach in such cases depends on the type
of leakage (16,19). In this study, primary leakage
was found in one case, and it was observed that the
leakage thrombosed and disappeared completely
during follow-up.
Although EVAR is a method that is widely used,
endovascular treatment with the Endologix stent graft
(bifurcated system) is a new approach. Limitations of
the present study were the low number of cases, the
absence of long-term outcomes versus surgery, and
the use of a new device. New studies that include no
limitations are necessary.
In conclusion, the new bifurcated system
(nonmigration system) has several advantages, such
as having a very small insertion site at the femoral
artery, low mortality and morbidity rates, a shorter
hospitalization period, and lower blood loss and
smaller transfusion requirements.
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